ARMO BioSciences Inc (ARMO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

575 CHESAPEAKE DRIVE REDWOOD CITY, CA 94063

ARMO BioSciences, Inc. operates as a bio-technology company. The Company develops immunotherapies for the treatment of cancer, cardiovascular, fibrosis, and inflammation diseases. ARMO BioSciences serves clients in the United States.

Data as of 2019-05-25 05:54:06 -0400
Market Cap1.52 Billion Shares Outstanding30.405 Million Avg 30-day Volume
P/E Ratio Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA0
Price to Book Value9.69 Forward PE Enterprise Value
Total Cash0 Current Debt Gross Profit0
BETA2.78692 52-week High/Low57.19 / 25.1 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from ARMO instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VAN VLASSELAER PETER PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2018-06-22 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP IV LLC

ORBIMED CAPITAL GP V LLC

  • Director
  • 10% Owner
No longer subject to file 2018-06-22 0

CROSS HERB CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2018-06-22 0

GORDON CARL L

  • Director
No longer subject to file 2018-06-22 0

LEVEQUE JOSEPH CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2018-06-22 0

KLEINER PERKINS CAUFIELD & BYERS XIV, LLC

KLEINER PERKINS CAUFIELD & BYERS XVI, LLC

KPCB XIV ASSOCIATES, LLC

KPCB XIV FOUNDERS FUND, LLC

KPCB XVI ASSOCIATES, LLC

KPCB XVI FOUNDERS FUND, LLC

  • 10% Owner
No longer subject to file 2018-06-22 0

XU STELLA

  • Director
No longer subject to file 2018-06-22 0

CUI XIANGMIN

  • Director
No longer subject to file 2018-06-22 0

SEIDENBERG BETH C

  • Director
No longer subject to file 2018-06-22 0

RIZVI NAIYER

  • Director
No longer subject to file 2018-06-22 0

LEGAULT PIERRE

  • Director
0 2018-03-26 0

DAG VENTURES MANAGEMENT V, LLC

DAG VENTURES V-QP, L.P.

DAG VENTURES V, L.P.

CADEDDU JOHN J.

GOODRICH R. THOMAS

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-01-30 0

GV 2016 GP, L.L.C.

GV 2016 GP, L.P.

GV 2016, L.P.

ALPHABET INC.

  • 10% Owner
No longer subject to file 2018-01-30 0

GV 2014 GP, L.L.C.

GV 2014, L.P.

ALPHABET INC.

  • 10% Owner
No longer subject to file 2018-01-30 0

SC CHINA VENTURE VI MANAGEMENT, L.P.

SHEN NEIL NANPENG

SNP CHINA ENTERPRISES LTD

SC CHINA HOLDING LTD

SCC VENTURE VI HOLDCO, LTD.

SEQUOIA CAPITAL CHINA VENTURE FUND VI, L.P.

  • 10% Owner
No longer subject to file 2018-01-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments